Mark S. Ordan appointed CEO of Pediatrix Medical Group effective Jan 12, 2025

Pediatrix Medical Group, Inc.

Mark Ordan, 65, appointed CEO; he was CEO from 2020-2022 and most recently Executive Chair, succeeding Dr. Swift.
Employment agreement: $1M base salary, $2M one-time cash retention award, annual bonus target 150% of salary.
Equity transformation award: 640,000 performance share units with stock price hurdles of 125%, 150%, and 175%.
Annual equity grants of at least $5.5M; severance for cause-less termination: 2x base+bonus, 3x under change in control.
Dr. Swift's departure is termination without cause; he will receive severance benefits under prior employment agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark S. Ordan

Chief Executive Officer

MD · Pediatrix Medical Group, Inc.

Effective: 2025-01-12
Filed: January 14, 2025, 6:59 PM ET

appointed Mr. Mark S. Ordan to serve as the Company’s Chief Executive Officer and principal executive officer, succeeding Dr. James D. Swift.

Departed

Dr. James D. Swift

Other Named Officer

MD · Pediatrix Medical Group, Inc.

Effective: 2025-01-12
Successor: Mark S. Ordan
Filed: January 14, 2025, 6:59 PM ET

succeeding Dr. James D. Swift.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark S. Ordan was appointed as Chief Executive Officer at Pediatrix Medical Group, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

appointed Mr. Mark S. Ordan to serve as the Company’s Chief Executive Officer and principal executive officer, succeeding Dr. James D. Swift.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.75

Dr. James D. Swift departed as other_named_officer at Pediatrix Medical Group, Inc..

Exact text from the filing

succeeding Dr. James D. Swift.

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-006190

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.